Skip to main content
. 2024 Mar 17:19322968241231950. Online ahead of print. doi: 10.1177/19322968241231950

Table 1.

Study Participant Characteristics at Baseline, by Treatment Group.

Characteristic AID Control
Number of subjects, N 65 68
Age, years (%) 13.1 ± 2.6 12.8 ± 2.9
6-12 29 (45%) 30 (44%)
13-18 36 (55%) 38 (56%)
Range 7.5-18.4 6.3-18.4
Gender, N (%)
Female 37 (57) 39 (57)
Male 28 (43) 29 (43)
Diabetes duration, years 6.3 ± 3.3 6.6 ± 3.1
Total daily insulin dose, U/kg/day 0.93 ± 0.23 0.95 ± 0.24
Continuous glucose monitor (CGM) use, N (%)
Current 45 (69%) 44 (65%)
In past, but not current 12 (18%) 14 (21%)
Never 8 (12%) 10 (15%)
BMI percentile 60 ± 25 67 ± 25
BMI z-score 0.35 ± 0.86 0.58 ± 0.89
Ethnicity, N (%)
White non-Hispanic 60 (94%) 53 (79%)
Black non-Hispanic 0 (0) 2 (3%)
Hispanic or Latino 0 (0) 4 (6%)
Asian 3 (5%) 4 (6%)
Native Hawaiian/Other Pacific Islander 0 (0) 1 (1%)
More than one race 1 (2%) 3 (4%)
Highest parent education level, N (%)
High school diploma or less 7 (11%) 2 (3%)
Associates degree or some College but no degree 17 (28%) 19 (30%)
Bachelor’s degree 18 (30%) 13 (20%)
Master’s degree 8 (13%) 15 (23%)
Doctoral or professional degree 11 (18%) 15 (23%)
Glycated hemoglobin at baseline, mmol/mol (%) 66 ± 8 67 ± 8
[8.2 ± 0.7] [8.3 ± 0.8]
Range (%) 53-83 53-89
[7.0-9.7] [7.0-10.3]
<64 mmol/mol (<8.0%), N (%) 28 (43%) 29 (43%)
64 to <75 mmol/mol (8.0 to <9.0%), N (%) 26 (40%) 25 (37%)
≥75 mmol/mol (≥9.0%), N (%) 11 (17%) 14 (21%)